These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal. Wang HX; Zhang L; Liang ZT; Nie JH; Wu JJ; Li QQ; Ding RX; Zhang Y; Chen GQ; Wang YC; Wang HG; Huang WJ Arch Virol; 2022 Feb; 167(2):459-470. PubMed ID: 35083576 [TBL] [Abstract][Full Text] [Related]
27. Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y. Zhu Y; Zhou W; Niu Z; Sun J; Zhang Z; Li Q; Zheng Y; Wang C; Gao L; Sun Q Biol Direct; 2022 Jun; 17(1):14. PubMed ID: 35658928 [TBL] [Abstract][Full Text] [Related]
28. The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera. Li G; Zhou Z; Du P; Yu M; Li N; Xiong X; Huang H; Liu Z; Dai Q; Zhu J; Guo C; Wu S; Baptista-Hon DT; Miao M; Ming LW; Wu Y; Zeng F; Zhang CL; Zhang ED; Song H; Liu J; Lau JY; Xiang AP; Zhang K Precis Clin Med; 2021 Sep; 4(3):149-154. PubMed ID: 35693215 [TBL] [Abstract][Full Text] [Related]
29. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern. Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR Front Immunol; 2021; 12():691715. PubMed ID: 34149735 [TBL] [Abstract][Full Text] [Related]
30. The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another. Blairon L; Cupaiolo R; Piteüs S; Beukinga I; Tré-Hardy M J Virol Methods; 2021 Nov; 297():114248. PubMed ID: 34332998 [TBL] [Abstract][Full Text] [Related]
31. Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity. Tang H; Gao L; Wu Z; Meng F; Zhao X; Shao Y; Shi X; Qiao S; An J; Du X; Qin FX Front Cell Infect Microbiol; 2021; 11():720357. PubMed ID: 34722330 [TBL] [Abstract][Full Text] [Related]
32. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
34. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants. Wang Q; Ye SB; Zhou ZJ; Li JY; Lv JZ; Hu B; Yuan S; Qiu Y; Ge XY J Med Virol; 2023 Jan; 95(1):e28116. PubMed ID: 36056469 [TBL] [Abstract][Full Text] [Related]
35. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination. Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648 [TBL] [Abstract][Full Text] [Related]
36. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
37. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study. Zhao S; Ran J; Han L Am J Trop Med Hyg; 2021 Sep; 105(5):1247-1254. PubMed ID: 34583340 [TBL] [Abstract][Full Text] [Related]